17-49716283-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_030802.4(FAM117A):c.943G>A(p.Asp315Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000186 in 1,606,058 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030802.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM117A | NM_030802.4 | c.943G>A | p.Asp315Asn | missense_variant | 7/8 | ENST00000240364.7 | NP_110429.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM117A | ENST00000240364.7 | c.943G>A | p.Asp315Asn | missense_variant | 7/8 | 1 | NM_030802.4 | ENSP00000240364.2 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000132 AC: 32AN: 242342Hom.: 0 AF XY: 0.000130 AC XY: 17AN XY: 130606
GnomAD4 exome AF: 0.000186 AC: 270AN: 1453908Hom.: 2 Cov.: 34 AF XY: 0.000183 AC XY: 132AN XY: 722646
GnomAD4 genome AF: 0.000191 AC: 29AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 24, 2024 | The c.943G>A (p.D315N) alteration is located in exon 7 (coding exon 7) of the FAM117A gene. This alteration results from a G to A substitution at nucleotide position 943, causing the aspartic acid (D) at amino acid position 315 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at